• OPEN AN ACCOUNT
Indian Indices
Sensex
73,123.83 -125.56
( -0.17%)
Global Indices
Nasdaq
52,230.09 -658.89
(-1.25%)
Dow Jones
7,644.13 -40.30
(-0.52%)
Hang Seng
62,584.98 -322.86
(-0.51%)
Nikkei 225
10,670.63 -54.40
(-0.51%)
Forex
USD-INR
94.61 0.10
(0.11%)
EUR-INR
106.18 0.08
(0.07%)
GBP-INR
126.70 0.19
(0.15%)
JPY-INR
0.60 0.00
(0.70%)

EQUITY - MARKET SCREENER

C2C Advanced Systems Ltd
Industry :  Engineering
BSE Code
ISIN Demat
Book Value()
93016
INE0U7V01015
139.3633301
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
C2C
13.33
244.35
EPS(TTM)
Face Value()
Div & Yield %
10.8
10
0
 

Aurobindo Pharma's Unit-VI completes USFDA inspection
Aug 28,2026
Aurobindo Pharma announced that United States Food and Drug Administration (US FDA) inspected Unit-VI, an API manufacturing facility of Apitoria Pharma, a wholly owned subsidiary of the Company, situated at E-Bonangi Village, Parawada Mandal, Anakapalli District, 531019, Andhra Pradesh from 24 August to 28 August 2026. The inspection concluded with three observations, which are procedural in nature.